StonvexLoading…
StonvexCore line items from MTLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | €266.76M | €256.13M | €232.02M | €205.45M |
Operating Income | €9.43M | €5.62M | €-2.87M | €12.22M |
Net Income | €13.41M | €6.70M | €-2.15M | €13.14M |
EPS (Diluted) | €0.23 | €0.11 | €-0.04 | €0.23 |
Total Assets | €396.34M | €396.63M | €411.26M | €413.41M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | €102.30M | €127.57M | €140.87M | €196.03M |
Free Cash Flow OCF − CapEx | €6.81M | €10.92M | €680.00K | €17.91M |
Shares Outstanding | Not available | Not available | Not available | Not available |